Bausch & Lomb expands Waterford contact lens plant
Production lines for new lenses will create 100 jobs over the next four years
Perrigo sells Tysabri rights to Royalty Pharma in €2.7bn deal
Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013
Perrigo makes board changes under pressure from activist investor
Dublin-based drugmaker was urged last year to explore a sale of its prescription business
Valeant is selling assets to help pay down long-term debt
Announcement by Canadian pharmaceutical company drives its shares up by 13%
Failed Perrigo suitor Mylan sees revenues rise on generic drugs
Dutch-domiciled US group says it is still fully committed to planned $7.2bn takeover of Sweden’s Meda
Cantillon: Valeant swipes Papa from Perrigo
What Papa brings to the party is a depth of experience from over 30 years in the business
Perrigo pays executives bonuses for fending off Mylan offers
Dublin-based drugmaker’s chief executive Joe Papa receives additional stock and bonus
Perrigo executives head for Israel in battle against Mylan
CEO Joe Papa and CFOJudy Brown hope to persuade Israeli holders of 10% of company not to accept takeover offer
Irish takeover panel rejects Perrigo's request over Mylan offer
Offer from Mylan remains valid and capable of acceptance by Perrigo shareholders
Perrigo files lawsuit against suitor Mylan
Irish pharma company claims Mylan’s $27bn offer overstates potential synergies and makes false claims
Mylan ready to make $33 billion hostile bid for Perrigo
Company’s shareholders vote to move forward with mega-merger of pharma groups
Drug firm Perrigo buys OTC portfolio of drugs from GSK
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle
Cantillon: Perrigo at wrong end of another deal
Perrigo chief executive Joe Papa and Mylan chairman Robert Coury talking about merger for some time
Perrigo offloads Elan Alzheimer drug candidate
Company does deal with partner Transition Therapeutics as it separately spends $51m on over-the-counter products in Australia
Takeover of Elan the perfect fit in Perrigo’s prescription for growth
For Perrigo chief Joe Papa, the acquisition of Ireland’s largest indigenous drug company was a ‘perfect gateway’ in its plans to expand internationally
Cantillon: Curtain comes down on Elan
Perrigo completes acquisition of Irish drugs firm in $8.6bn deal
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices